Treatment decisions, including dosing, should be guided by a licensed provider based on clinical considerations
Its agonists may provide new therapeutic directions for metabolic diseases, while studies on antagonists help us understand the inhibitory effects of GPER under pathological conditions
The supernatant was reacted with 10 mM acid ninhydrin solution dissolved in 80% ethanol and 0.2 mM citrate buffer (pH 5.0) using the diluent solution (water: n-propanol = 1:1)
Undoubtedly, more sophisticated studies are needed to define the interaction network of ERAD during disease progression and to understand the effects of targeting ERAD while preserving the physiological functions of ERAD, which could help not only pave the way for new therapeutic strategies but also uncover potent and durable combination treatments
Peptides including Tesamorelin, AOD-9604, Tesofensine, FTPP, and MOTS-c are highlighted, and their distinct mechanismssuch as promoting lipolysis, enhancing metabolic efficiency, and controlling appetiteare described
